Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Overcoming amphotericin B resistance in Candida auris using the antiemetic drug rolapitant.

  • Authors : Salama EA; Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.; Center for One Health Research, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.

Subjects: Amphotericin B*/Amphotericin B*/Amphotericin B*/pharmacology ; Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/pharmacology ; Microbial Sensitivity Tests*

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Nov 06; Vol. 68 (11), pp. e0055624. Date of Electronic Publication: 2024 OctPublisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for Candida infections.

  • Authors : Matusik E; Hospices Civils de Lyon, GH Nord, Service de Pharmacie, Lyon, France.; LBBE - Laboratoire de Biométrie et Biologie Evolutive, CNRS, UMR 5558, Université Lyon 1, Villeurbanne, France.

Subjects: Fluconazole*/Fluconazole*/Fluconazole*/pharmacokinetics ; Fluconazole*/Fluconazole*/Fluconazole*/therapeutic use ; Fluconazole*/Fluconazole*/Fluconazole*/pharmacology

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Nov 06; Vol. 68 (11), pp. e0099124. Date of Electronic Publication: 2024 SepPublisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.

  • Authors : Chen T; Department of Pathogen Biology, Jiangsu Key Laboratory of Pathogen Biology, Nanjing Medical University , Nanjing, Jiangsu, China.; Department of Respiratory Medicine, The Second Affiliated Hospital of Nanjing Medical University , Nanjing, Jiangsu, China.

Subjects: Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/pharmacology ; Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/therapeutic use ; Candidiasis*/Candidiasis*/Candidiasis*/drug therapy

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0113123. Date of Electronic Publication: 2023 Nov Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.

  • Authors : Desai JV; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.; Urban A

Subjects: Amphotericin B*/Amphotericin B*/Amphotericin B*/adverse effects ; Candidiasis*/Candidiasis*/Candidiasis*/drug therapy ; Candidiasis, Chronic Mucocutaneous*/Candidiasis, Chronic Mucocutaneous*/Candidiasis, Chronic Mucocutaneous*/drug therapy

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jul 19; Vol. 66 (7), pp. e0030822. Date of Electronic Publication: 2022 Jun Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Limitations of antifungal prophylaxis in preventing invasive Candida surgical site infections after liver transplant surgery.

  • Authors : Carugati M; Department of Medicine, Division of Infectious Diseases, Duke University, Durham, North Carolina, USA.; Arif S

Subjects: Liver Transplantation*/Liver Transplantation*/Liver Transplantation*/adverse effects ; Candidiasis, Invasive*/Candidiasis, Invasive*/Candidiasis, Invasive*/drug therapy ; Candidiasis, Invasive*/Candidiasis, Invasive*/Candidiasis, Invasive*/prevention & control Systemic candidiasis

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Mar 06; Vol. 68 (3), pp. e0127923. Date of Electronic Publication: 2024 Feb Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Therapeutic effect of iturin A on Candida albicans oral infection and its pathogenic factors.

  • Authors : Han D; School of Life Sciences, Northwestern Polytechnical University , Xi'an, Shaanxi Province, China.; Ji Y

Subjects: Candida albicans* ; Candidiasis*/Candidiasis*/Candidiasis*/drug therapy; Female

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0094823. Date of Electronic Publication: 2023 Dec Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.

  • Authors : Novy E; Faculty of Medicine, University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland , Brisbane, Queensland, Australia.; Université de Lorraine, SIMPA , Nancy, France.

Subjects: Candidiasis*/Candidiasis*/Candidiasis*/drug therapy ; Continuous Renal Replacement Therapy* ; Extracorporeal Membrane Oxygenation*

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0120123. Date of Electronic Publication: 2023 Dec Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

DectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis.

  • Authors : Ambati S; Department of Genetics, University of Georgiagrid.213876.9, Athens, Georgia, USA.; Pham T

Subjects: Candidiasis*/Candidiasis*/Candidiasis*/microbiology ; Liposomes*/Liposomes*/Liposomes*/chemistry; Animals

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jan 18; Vol. 66 (1), pp. e0146721. Date of Electronic Publication: 2021 Oct Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy.

  • Authors : Scott NE; University of Minnesota, Bioinformatics and Computational Biology Program, Minneapolis, Minnesota, USA.; University of Minnesota, Department of Microbiology and Immunology, Minneapolis, Minnesota, USA.

Subjects: Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/pharmacology ; Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/therapeutic use ; Candidiasis*/Candidiasis*/Candidiasis*/drug therapy Clavispora lusitaniae

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Aug 17; Vol. 67 (8), pp. e0054323. Date of Electronic Publication: 2023 Jul Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the Treatment of Emerging Candida auris Using an Immunocompromised Murine Model of Disseminated Candidiasis.

  • Authors : Gamal A; Center for Medical Mycology, Department of Dermatology, Case Western Reserve Universitygrid.67105.35, Cleveland, Ohio, USA.; Long L

Subjects: Candidiasis*/Candidiasis*/Candidiasis*/drug therapy ; Fluconazole*/Fluconazole*/Fluconazole*/pharmacology ; Fluconazole*/Fluconazole*/Fluconazole*/therapeutic use

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Aug 17; Vol. 65 (9), pp. e0054921. Date of Electronic Publication: 2021 Aug Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  1,184 results for ""Candidiasis""